Cargando…
Hypertrophic Cardiomyopathy: From Phenotype and Pathogenesis to Treatment
Hypertrophic cardiomyopathy (HCM) is a very common inherited cardiovascular disease (CAD) and the incidence is about 1/500 of the common population. It is caused by more than 1,400 mutations in 11 or more genes encoding the proteins of the cardiac sarcomere. HCM presents a heterogeneous clinical pro...
Autores principales: | Cheng, Zeyi, Fang, Tingting, Huang, Jinglei, Guo, Yingqiang, Alam, Mahboob, Qian, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572854/ https://www.ncbi.nlm.nih.gov/pubmed/34760939 http://dx.doi.org/10.3389/fcvm.2021.722340 |
Ejemplares similares
-
Bioinformatics and Immune Infiltration Analyses Reveal the Key Pathway and Immune Cells in the Pathogenesis of Hypertrophic Cardiomyopathy
por: Zhang, Xu-Zhe, et al.
Publicado: (2021) -
Different phenotype of left atrial function impairment in patients with hypertrophic cardiomyopathy and hypertension: comparison of healthy controls
por: Li, Hongwen, et al.
Publicado: (2023) -
Anxiety Predicts Poor Prognosis in Patients With Hypertrophic Cardiomyopathy
por: He, Chao-Jie, et al.
Publicado: (2022) -
Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy via a Microarray Data Analysis
por: Wang, Zuoxiang, et al.
Publicado: (2022) -
COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Arabadjian, Milla E., et al.
Publicado: (2021)